The Department of Drug Administration (DDA) granted the approval for the use of CoronaVac, a Chinese COVID-19 vaccine, manufactured by Sinovac life sciences company limited, in Nepal.
The DDA has already given permission for the use of Sinopharm COVID-19 vaccine (commonly understood as Vero Cell in Nepal), another Chinese COVID-19 vaccine, produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
China has provided 1.8 million doses of Sinopharm COVID-19 vaccine as grant assistance to Nepal.
World Health Organisation (WHO) has listed both the COVID-19 vaccines for emergency use, giving the green light for these vaccines to be rolled out globally.
- PATA Celebrates 47th Anniversary
- Sep 29, 2022
- Japan, China Marks 50 Years Of Japan-China Ties normalized
- Sep 29, 2022
- 36 People Die Due To Dengue
- Sep 28, 2022
- Elections Commission Issues 60-point Directives To Political Parties
- Sep 28, 2022
- India Logs 3,230 COVID-19 Cases
- Sep 28, 2022
